Fluidigm Corporation (FLDM): Price and Financial Metrics


Fluidigm Corporation (FLDM): $7.41

0.11 (+1.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FLDM POWR Grades


  • Value is the dimension where FLDM ranks best; there it ranks ahead of 70.33% of US stocks.
  • FLDM's strongest trending metric is Quality; it's been moving down over the last 31 weeks.
  • FLDM's current lowest rank is in the Sentiment metric (where it is better than 4.25% of US stocks).

FLDM Stock Summary

  • With a one year PEG ratio of 484.82, Fluidigm Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.38% of US stocks.
  • As for revenue growth, note that FLDM's revenue has grown 24.9% over the past 12 months; that beats the revenue growth of 79.05% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for FLDM comes in at -4.04% -- higher than that of 30.7% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fluidigm Corp are MYSZ, SBBP, CRIS, CNET, and MORF.
  • FLDM's SEC filings can be seen here. And to visit Fluidigm Corp's official web site, go to www.fluidigm.com.

FLDM Valuation Summary

  • In comparison to the median Healthcare stock, FLDM's price/sales ratio is 11.11% lower, now standing at 3.2.
  • Over the past 127 months, FLDM's price/sales ratio has gone down 7.1.
  • Over the past 127 months, FLDM's price/earnings ratio has gone up 5.4.

Below are key valuation metrics over time for FLDM.

Stock Date P/S P/B P/E EV/EBIT
FLDM 2021-04-12 2.5 2.5 -6.5 -7.3
FLDM 2016-07-13 2.4 2.8 -4.9 -8.2
FLDM 2015-03-05 10.6 8.2 -23.4 -26.7
FLDM 2014-12-04 7.9 5.3 -17.6 -21.1
FLDM 2014-03-10 18.7 12.7 -79.6 -79.1
FLDM 2011-07-25 11.6 5.7 -23.0 -23.7

FLDM Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at 39.05%.
  • Its 3 year price growth rate is now at 26.18%.
  • Its 3 year revenue growth rate is now at 0.72%.
FLDM's revenue has moved up $39,154,000 over the prior 34 months.

The table below shows FLDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 143.321 -24.023 -55.861
2020-12-31 138.144 -15.417 -53.02
2020-09-30 125.976 -17.203 -47.679
2020-06-30 112.611 -17.152 -54.567
2020-03-31 114.749 -19.375 -55.305
2019-12-31 117.243 -35.21 -64.79

FLDM Price Target

For more insight on analysts targets of FLDM, see our FLDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.33 Average Broker Recommendation 1.33 (Strong Buy)

FLDM Stock Price Chart Interactive Chart >

Price chart for FLDM

FLDM Price/Volume Stats

Current price $7.41 52-week high $12.45
Prev. close $7.30 52-week low $3.71
Day low $7.20 Volume 882,700
Day high $7.51 Avg. volume 1,852,889
50-day MA $5.97 Dividend yield N/A
200-day MA $5.74 Market Cap 555.48M

Fluidigm Corporation (FLDM) Company Bio


Fluidigm Corporation develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. The company was founded in 1999 and is based in South San Francisco, California.


FLDM Latest News Stream


Event/Time News Detail
Loading, please wait...

FLDM Latest Social Stream


Loading social stream, please wait...

View Full FLDM Social Stream

Latest FLDM News From Around the Web

Below are the latest news stories about Fluidigm Corp that investors may wish to consider to help them evaluate FLDM as an investment opportunity.

Fluidigm gains on report that it's exploring a sale

janiecbros/E+ via Getty Images Fluidigm Corp. (FLDM) rose 5.5% in premarket trading on a report that the Covid-19 test maker is considering a sale. The medical technology firm is working with an adviser to see interest from possible buyers, according to a Bloomberg report. The company may garner interest from other health-care...

Seeking Alpha | July 28, 2021

Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale

Fluidigm Corp (NASDAQ: FLDM ) stock is trading higher in the premarket on a report that the Company is considering a sale. According to a Bloomberg report , the medical Full story available on Benzinga.com

Benzinga | July 28, 2021

Genotyping Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Illumina, Beckman Coulter, Agilent Technologies, Affymetrix, Fluidigm, Life Technologies, GE Heal

The documented report on Global Genotyping Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or not to []

Jumbo News | July 25, 2021

Library Preparation and Target Enrichment for Next Generation Sequencing Product Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Fluidigm, Roche, Illumina,

The documented report on Global Library Preparation and Target Enrichment for Next Generation Sequencing Product Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment []

Jumbo News | July 25, 2021

Sample Preparation Products for Next Generation Sequencing Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:10X Genomics, Pacific Biosciences, Fluidigm, Agilent

This report studies the Sample Preparation Products for Next Generation Sequencing Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Sample Preparation Products []

Jumbo News | July 24, 2021

Read More 'FLDM' Stories Here

FLDM Price Returns

1-mo 26.88%
3-mo 41.95%
6-mo 11.09%
1-year 5.26%
3-year 14.71%
5-year -28.54%
YTD 23.50%
2020 72.41%
2019 -59.63%
2018 46.35%
2017 -19.09%
2016 -32.65%

Continue Researching FLDM

Want to see what other sources are saying about Fluidigm Corp's financials and stock price? Try the links below:

Fluidigm Corp (FLDM) Stock Price | Nasdaq
Fluidigm Corp (FLDM) Stock Quote, History and News - Yahoo Finance
Fluidigm Corp (FLDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7744 seconds.